Clinical and genetic characteristics and diagnostic features of Landouzy–Dejerine facioscapulohumeral muscular dystrophy

被引:0
作者
N. V. Zernov
A. V. Marakhonov
J. V. Vyakhireva
A. A. Guskova
E. L. Dadali
M. Yu. Skoblov
机构
[1] Research Centre of Medical Genetics,
[2] Evdokimov Moscow State University of Medicine and Dentistry,undefined
[3] Moscow Institute of Physics and Technology,undefined
来源
Russian Journal of Genetics | 2017年 / 53卷
关键词
Landouzy–Dejerine muscular dystrophy; pathogenesis of the disease; DNA diagnostics;
D O I
暂无
中图分类号
学科分类号
摘要
Landouzy–Dejerine facioscapulohumeral muscular dystrophy (FSHD) is one of the most common hereditary myodystrophies. A study of the genetic nature of the disease, which has an autosomal dominant mode of inheritance, is extremely interesting and revealing. A unique structure of D4Z4 macrosatellite repeats found in the 4q35 region was originally characterized by a decrease in the number of repeats in patients with Landouzy–Dejerine muscular dystrophy, which resulted in the activation of neighboring genes, in particular, the DUX4 transcription factor. Later, it was found that the epigenetic mechanisms responsible for the chromatin condensation of this region underlie the activation. To date, additional participants leading to pathogenesis of the disease, such as SMCHD1 methylation regulator and DBE-T regulatory long noncoding RNA, have been identified. The revealed complexity of the disease mechanisms is in good agreement with the observed pattern of the disease inheritance. The study of the Landouzy–Dejerine muscular dystrophy pathogenesis is a good example of how monogenic diseases can possess a more complex nature of inheritance.
引用
收藏
页码:640 / 650
页数:10
相关论文
共 192 条
[1]  
Padberg G.W.(1995)Facioscapulohumeral muscular dystrophy in the Dutch population Muscle Nerve Suppl. 2 S81-S84
[2]  
Frants R.R.(2001)Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy Neuromuscular Disord. 11 525-529
[3]  
Brouwer O.F.(2009)Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample Clin. Genet. 75 550-555
[4]  
Flanigan K.M.(2009)Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population Brain 132 3175-3186
[5]  
Coffeen C.M.(1995)High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families Am. J. Hum. Genet. 56 99-105
[6]  
Sexton L.(1995)The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter Muscle Nerve Suppl. 2 S39-S44
[7]  
Mostacciuolo M.L.(1993)Extreme variability of expression in monozygotic twins with FSH muscular dystrophy Neurology 43 345-348
[8]  
Pastorello E.(2008)Facioscapulohumeral muscular dystrophy Neurotherapeutics 5 601-606
[9]  
Vazza G.(2006)Modifications of brain tissue volumes in facioscapulohumeral dystrophy Neuroimage 32 1237-1242
[10]  
Norwood F.L.(2011)CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI J. Clin. Immunol. 31 155-166